5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.78▲ | 3.81▲ | 3.81▲ | 3.70▲ | 3.41▲ |
MA10 | 3.78▲ | 3.76▲ | 3.75▲ | 3.51▲ | 3.06▲ |
MA20 | 3.73▲ | 3.70▲ | 3.62▲ | 3.38▲ | 2.71▲ |
MA50 | 3.50▲ | 3.44▲ | 3.34▲ | 3.00▲ | 2.28▲ |
MA100 | 3.19▲ | 3.06▲ | 3.00▲ | 2.66▲ | 1.69▲ |
MA200 | 2.93▲ | 2.79▲ | 2.68▲ | 2.35▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.005▼ | -0.005▼ | 0.001▲ | 0.033▲ | 0.104▲ |
RSI | 62.983▲ | 63.410▲ | 65.049▲ | 75.167▲ | 85.467▲ |
STOCH | 60.103 | 79.781 | 66.385 | 80.624▲ | 83.211▲ |
WILL %R | -13.115▲ | -13.115▲ | -18.462▲ | -7.500▲ | -3.593▲ |
CCI | 101.297▲ | 108.627▲ | 76.788 | 147.810▲ | 166.696▲ |
MA | $PVL Price Crossed Above MA(7) | Set Alert |
Friday, May 20, 2022 09:18 AM
Boston Scientific (NYSE:BSX) announced positive outcomes from studies of its Acurate Neo2 aortic valve system.
|
Friday, May 20, 2022 09:18 AM
Boston Scientific (NYSE:BSX) announced positive outcomes from studies of its Acurate Neo2 aortic valve system.
|
Wednesday, May 18, 2022 08:01 AM
Doximity (NASDAQ:DOCS – Get Rating) had its target price decreased by stock analysts at Bank of America from $55.00 to $36.00 in a research note issued on Wednesday, Briefing.com reports.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
20/05/22 | 3.80 | 3.89 | 3.7501 | 3.85 | 179,552 |
19/05/22 | 3.53 | 3.80 | 3.50 | 3.73 | 214,483 |
18/05/22 | 3.64 | 3.79 | 3.64 | 3.67 | 233,483 |
17/05/22 | 3.63 | 3.91 | 3.5527 | 3.64 | 390,361 |
16/05/22 | 3.50 | 3.63 | 3.41 | 3.61 | 211,215 |
13/05/22 | 3.37 | 3.47 | 3.37 | 3.44 | 73,460 |
12/05/22 | 3.36 | 3.36 | 3.27 | 3.30 | 88,796 |
11/05/22 | 3.27 | 3.45 | 3.27 | 3.36 | 96,579 |
10/05/22 | 3.30 | 3.32 | 3.18 | 3.22 | 134,877 |
09/05/22 | 3.41 | 3.44 | 3.26 | 3.32 | 104,351 |
|
|
||||
|
|
||||
|
|